Everest Group, Ltd.

Company: Everest Group, Ltd.
Ticker: EG
Class Action Period: February 08, 2024 – October 27, 2025

59 Days Left Lead Plaintiff Deadline: December 28, 2026

Submit Your Information

If you suffered a loss on your Everest Group, Ltd. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Last Name*

Email*

Phone*

City

State

Country

Total # of shares

First Purchase Date

Last Purchase Date

Estimated Loss Range

Check here if you still hold any shares.

Check here if you are a current or former employee of the company.

Check here if you purchased any shares before February 08, 2024

Additional Comments

Background

On October 30, 2024, Everest released its third quarter 2024 results and disclosed that that loss activity in its U.S. casualty business had “definitely spiked” and that rate increases had accelerated into the high teens. Everest further disclosed that its annual casualty reserve review was underway and would be completed during the fourth quarter.

On this news, Everest stock fell $24.39 or 6.42%, to close at $355.61 per share on October 31, 2024, thereby injuring investors.

Then, on January 27, 2025, Everest announced $1.7 billion in reserve strengthening, including approximately $1.3 billion related to U.S. casualty losses in Everest’s Insurance segment, principally from accident years 2020 through 2024. Its new Chief Executive Officer (CEO) acknowledged that Everest's underwriting choices contributed significantly to the losses.

On this news, Everest stock fell $21.49 or 5.8% over the following two consecutive trading days, to close at $351.51 per share on January 29, 2025, thereby further injuring investors.

Then, on October 27, 2025, Everest disclosed $478 million in unfavorable prior-year reserve development, driven principally by U.S. casualty losses. Everest also entered into an agreement providing $1.2 billion in protection against further adverse development on approximately $5.4 billion of North American Insurance and Other segment reserves for accident years 2024 and prior.

On this news, Everest stock fell $39.07 or 11.4%, to close at $304.91 per share on October 28, 2025, further injuring investors.

The Action alleges that these representations were materially false and misleading because throughout the Class Period, Defendants knew or recklessly disregarded, but failed to disclose, that: (i) Everest remained materially exposed to and concentrated in casualty risks subject to escalating claim costs, including business Defendants claimed Everest had reduced or exited; (ii) Everest had inadequately priced portions of that business; (iii) Everests reserves were insufficient, causing it to understate its liabilities and expenses and materially overstate its earnings; and (iv) addressing these problems would require substantial reserve charges, protection against further adverse development, and reductions in Everests casualty business, thereby sacrificing recurring premium revenue.

Submit Your Information